Trial · NCT05943288
Safety and Efficacy of the Olympus CADe System in Real-time Colonoscopy
NCT05943288, Completed, Olympus Europe SE & Co. KG
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Safety and Efficacy of the Olympus CADe System in Real-time Colonoscopy. Trials, record NCT05943288. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05943288
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Safety and Efficacy of the Olympus CADe System in Real-time Colonoscopy
- NCT number
- NCT05943288
- Status
- Completed
- Enrollment
- 850 participants, actual
- Lead sponsor
- Olympus Europe SE & Co. KG
- Conditions
- Colorectal Cancer
- Interventions
- OIP-1
- First posted
- 2023-07-13
- Last updated
- 2025-03-18
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Adenoma Detection Rate (ADR) | During procedure | Proportion of patients with at least one histologically confirmed adenoma (including advanced adenomas) or carcinoma in the CADe assisted colonoscopy (CADe+ arm) versus conventional colonoscopy without CAD (CADe- arm). |
| Primary | Positive Predictive Value (PPV) | During procedure | Number of histologically confirmed polyps (i.e. adenomas, SSLs, or large (\>10mm) hyperplastic polyps divided by the total number of resections. |
| Secondary | Adenoma Per Colonoscopy (APC) | During procedure | Number of histologically proven adenomas (including advanced adenomas) or carcinomas divided by the total number of colonoscopies |
| Secondary | Total Procedure Time | During procedure | Time from procedure start (insertion of the colonoscope) until colon inspection during a typical withdrawal from cecum to rectosigmoid including any time needed for interventional procedures (biopsies, resection). |
| Secondary | Endoscope withdrawal time | During procedure | Time from deepest point of insertion (cecum) needed for complete inspection of the colon, excluding time spent on therapeutic intervention. |
| Other | Adverse events (AEs) | During procedure | Device-, or procedure-related AEs and Serious AEs (SAEs) reported as incidence (%) and frequency (n). |
| Other | Non-neoplastic resection rate | During procedure | Number of patients with no histological confirmation of adenoma, advanced adenoma, SSL, large hyperplastic polyp or carcinoma in any excised lesion divided by the number of colonoscopies where at least one polyp was resected |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05943288
GET https://conductscience.org/api/trials/v1/NCT05943288/registered